Elevance Health ELV Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $50.18B+2.6% | $49.75B+9.5% | $50.71B+12.4% | $49.78B+13.4% | $48.89B+14.8% | ||
| $5.46B+9.6% | $5.52B-8.2% | $5.38B+5.6% | $5.29B+9.8% | $4.98B+30.3% | ||
| $44.72B+1.8% | $44.23B+12.2% | $45.33B+13.3% | $44.48B+13.9% | $43.91B+13.3% | ||
| 89.1%-0.7pp | 88.9%+2.1pp | 89.4%+0.7pp | 89.4%+0.3pp | 89.8%-1.2pp | ||
| $6.33B+19.4% | $5.42B+12.7% | $5.27B+0.1% | $5B-1.4% | $5.3B+8.5% | ||
| $357M+3.8% | $366M+7.6% | $351M+17.0% | $341M+21.8% | $344M+29.8% | ||
| $2.3B-17.6% | $215M-64.5% | $1.41B+2.4% | $2.29B-23.2% | $2.8B-4.8% | ||
| $544M-11.3% | —— | $219M-40.0% | $548M-20.0% | $613M-11.2% | ||
| $1.76B-19.2% | $547M+30.9% | $1.19B+17.0% | $1.74B-24.2% | $2.18B-2.8% | ||
| 3.5%-0.9pp | 1.1%+0.2pp | 2.3%+0.1pp | 3.5%-1.7pp | 4.5%-0.8pp | ||
| $8.00-16.8% | $2.54+35.8% | $5.32+22.0% | $7.72-21.6% | $9.61+0.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Elevance Health's revenue?
- Elevance Health (ELV) generated $200.42B in revenue over the trailing twelve months, up 9.3% year over year.
- Is Elevance Health profitable?
- Elevance Health reported $5.2B in net income over the trailing twelve months, a 2.6% net margin.
- What is Elevance Health's earnings per share?
- Elevance Health's diluted EPS over the trailing twelve months is $23.58.
- Where does Elevance Health's income statement data come from?
- Every line is extracted from Elevance Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
